HRMY
Harmony Biosciences Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$27.61
-0.18 ▼ -0.65%
🌙 3월 13일 6:01 PM ET (한국 3/14 07:01)
$27.72
+0.11 ▲ +0.40%
| Index | RUT | P/E | 10.19 | EPS (ttm) | 2.71 | Insider Own | 13.08% | Shs Outstand | 0.06B | Perf Week | -2.54% |
| Market Cap | 1.60B | Forward P/E | 6.54 | EPS next Y | 18.94% | Insider Trans | -0.97% | Shs Float | 0.05B | Perf Month | -24.54% |
| Enterprise Value | 1.06B | PEG | 0.3 | EPS next Q | 0.78 | Inst Own | 89.52% | Short Float | 15.81% | Perf Quarter | -29.69% |
| Income | 0.16B | P/S | 1.84 | EPS this Y | 31.06% | Inst Trans | 4.48% | Short Ratio | 9.21 | Perf Half Y | -17.38% |
| Sales | 0.87B | P/B | 1.83 | EPS next 5Y | 21.59% | ROA | 13.98% | Short Interest | 7.95M | Perf YTD | -26.22% |
| Book/sh | 15.07 | P/C | 2.06 | EPS past 3/5Y | -3% - | ROE | 20.75% | 52W High | -32.44% ($40.87) | Perf Year | -15.62% |
| Cash/sh | 13.4 | P/FCF | 4.59 | Sales past 3/5Y | 25.64% 40.3% | ROIC | 15.58% | 52W Low | 8.19% ($25.52) | Perf 3Y | -33.5% |
| Dividend Est. | - | EV/EBITDA | 4.52 | EPS Y/Y TTM | 8.01% | Gross Margin | 74.42% | Volatility(W/M) | 2.89% 5.32% | Perf 5Y | -9.53% |
| Dividend TTM | - | EV/Sales | 1.22 | Sales Y/Y TTM | 21.51% | Oper. Margin | 24% | ATR (14) | 1.37 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.58 | EPS Q/Q | -54.92% | Profit Margin | 18.27% | RSI (14) | 30.21 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.6 | Sales Q/Q | 21.12% | SMA20 | -7.45% ($29.83) | Beta | 0.91 | Target Price | $42 |
| Payout | - | Debt/Eq | 0.27 | Earnings | 2000000 | SMA50 | -19.12% ($34.14) | Rel Volume | 0.55 | Prev Close | $27.79 |
| Employees | 293 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | -56.61% 1.44% | SMA200 | -18.2% ($33.75) | Avg Volume(3M) | 0.86M | Price | $27.61 |
| IPO | 2020/8/19 | Option/Short | Yes/Yes | Trades | 7342 | Volume | 478,788 | Change | -0.65% |
뉴스 로딩 중...